Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00769
|
|||||
| Drug Name |
Vorinostat
|
|||||
| Synonyms |
M344; MK-0683; MK0683; Merck brand of Vorinostat; N'-hydroxy-N-phenyloctanediamide; N-Hydroxy-N'-phenyl octanediamide; N-Hyrdroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide; N-hydroxy-N'-phenyloctanediamide; N1-hydroxy-N8-phenyloctanediamide; NHNPODA; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; SAHA; SAHA cpd; SAHA, Suberoylanilide hydroxamic acid; SHH; SKI390; SW-064652; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid; Vorinostat (HDAC inhibitor); Vorinostat (JAN/USAN); Vorinostat MSD; Vorinostat [USAN]; WIN64652; Zolinza; Zolinza (TN); Zolinza, MK-0683, SAHA
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H20N2O3
|
|||||
| Canonical SMILES |
C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
|
|||||
| InChI |
InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)
|
|||||
| InChIKey |
WAEXFXRVDQXREF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 149647-78-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 264.32 | Topological Polar Surface Area | 78.4 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 8 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.